NEW YORK MiMedx Group Inc finalized a deal Sunday to acquire Stability Biologics for $10 million in cash and stock.
The regenerative medicine company MiMedx said the acquisition of Stability Biologics, a provider of human tissue and bone graft products, adds a new sales channel and roughly 100 salespeople to the company.
13:37 GoPro to cut about 15 percent of workforce13
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff14
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle17
16:38 Swift Energy completes $40 million sale of Louisiana asset10